VivoSim Labs, Inc. (VIVS)
2.22
-0.04
(-1.77%)
USD |
NASDAQ |
Dec 12, 16:00
2.14
-0.08
(-3.60%)
After-Hours: 20:00
VivoSim Labs EPS Diluted (Quarterly): -0.977 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CEL-SCI Corp. | -1.365 |
| AIM ImmunoTech, Inc. | -1.569 |
| IGC Pharma, Inc. | -0.0201 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Protalix Biotherapeutics, Inc. | 0.0291 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.545M |
| Revenue (Quarterly) | 0.028M |
| Total Expenses (Quarterly) | 2.573M |
| Enterprise Value | 0.1466M |
| Gross Profit Margin (Quarterly) | -110.7% |
| Profit Margin (Quarterly) | -9.09K% |
| Earnings Yield | -35.73% |
| Normalized Earnings Yield | -35.73 |